Phenotypic and molecular characterization of Madurella pseudomycetomatis sp. nov., a novel opportunistic fungus possibly causing black-grain mycetoma

Journal of Clinical Microbiology

Volumn 48, Issue 1, 2010, Pages 251-257

  Yan, Jie ^a   Deng, Jun ^a   Zhou, Cun Jian ^a   Zhong, Bai Yu ^a   Hao, Fei ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN; AMPHOTERICIN B; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; FLUCONAZOLE; FLUCYTOSINE; INTERNAL TRANSCRIBED SPACER; ITRACONAZOLE; PENICILLIN G; RIBOSOME DNA; TERBINAFINE; VORICONAZOLE;

ADULT; ANAMNESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DEBRIDEMENT; EUMYCETOMA; FUNGAL STRAIN; GENE SEQUENCE; GRANULOMATOUS INFLAMMATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LABORATORY TEST; MADURELLA; MALE; MANDIBLE FRACTURE; MOLECULAR PHYLOGENY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PHYSICAL EXAMINATION; PRIORITY JOURNAL;

ADULT; ANIMALS; ANTIFUNGAL AGENTS; CHINA; DISEASE MODELS, ANIMAL; DNA, FUNGAL; DNA, RIBOSOMAL; DNA, RIBOSOMAL SPACER; FEMALE; GENES, RRNA; HUMANS; JAW DISEASES; MADURELLA; MALE; MICE; MICE, INBRED BALB C; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; MYCETOMA; RNA, FUNGAL; RNA, RIBOSOMAL, 28S; SEQUENCE ANALYSIS, DNA;

FUNGI; MADURELLA;

EID: 73949098094     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.00018-09     Document Type: Article

References (27)

1. Ahmed, A., D. Adelmann, A. Fahal, H. Verbrugh, A. van Belkum, and S. de Hoog. 2002. Environmental occurrence of Madurella mycetomatis, the major agent of human eumycetoma in Sudan. J. Clin. Microbiol. 40:1031-1036.
2. Ahmed, A. O., M. M. Mukhtar, M. Kools-Sijmons, A. H. Fahal, S. de Hoog, B. G. van den Ende, E. E. Zijlstra, H. Verbrugh, E. S. Abugroun, A. M. Elhassan, and A. van Belkum. 1999. Development of a species-specific PCR-restriction fragment length polymorphism analysis procedure for identification of Madurella mycetomatis. J. Clin. Microbiol. 37:3175-3178.
3. Ahmed, A. O., N. Desplaces, P. Leonard, F. Goldstein, S. De Hoog, H. Verbrugh, and A. van Belkum. 2003. Molecular detection and identification of agents of eumycetoma: detailed report of two cases. J. Clin. Microbiol. 41:5813-5816.
4. Ahmed, A. O., W. van Leeuwen, A. Fahal, W. van de Sande, H. Verbrugh, and A. van Belkum. 2004. Mycetoma caused by Madurella mycetomatis: a neglected infectious burden. Lancet Infect. Dis. 4:566-574.
5. Ahmed, A., W. van de Sande, H. Verbrugh, A. Fahal, and A. van Belkum. 2003. Madurella mycetomatis strains from mycetoma lesions in Sudanese patients are clonal. J. Clin. Microbiol. 41:4537-4541.
6. Ahmed, A. O., W. van Vianen, M. T. ten Kate, W. W. van de Sande, A. van Belkum, A. H. Fahal, H. A. Verbrugh, and I. A. Bakker-Woudenberg. 2003. A murine model of Madurella mycetomatis eumycetoma. FEMS Immunol. Med. Microbiol. 37:29-36.
7. Ahmed, A. O., W. W. van de Sande, W. van Vianen, A. van Belkum, A. H. Fahal, H. A. Verbrugh, and I. A. Bakker-Woudenberg. 2004. In vitro susceptibilities of Madurella mycetomatis to itraconazole and amphotericin B assessed by a modified NCCLS method and a viability-based 2, 3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino)carbonyl]-2H-tetrazolium hydroxide (XTT) assay. Antimicrob. Agents Chemother. 48:2742-2746.
8. Chen, Y. C., J. D. Eisner, M. M. Kattar, S. L. Rassoulian-Barrett, K. Lafe, S. L. Yarfitz, A. P. Limaye, and B. T. Cookson. 2000. Identification of medically important yeasts using PCR-based detection of DNA sequence polymorphisms in the internal transcribed spacer 2 region of the rRNA genes. J. Clin. Microbiol. 38:2302-2310.
9. Chen, Y. C., J. D. Eisner, M. M. Kattar, S. L. Rassoulian-Barrett, K. Lafe, U. Bui, A. P. Limaye, and B. T. Cookson. 2001. Polymorphic internal transcribed spacer region 1 DNA sequences identify medically important yeasts. J. Clin. Microbiol. 39:4042-4051.
10. Conde, C., E. I. Melendro, M. Fresán, and L. Ortiz-Ortiz. 1982. Nocardia brasiliensis: mycetoma induction and growth cycle. Infect. Immun. 38:1291-1295.
11. de Hoog, G. S., A. Buiting, C. S. Tan, A. B. Stroebel, C. Ketterings, E. J. de Boer, B. Naafs, R. Brimicombe, M. K. Nohlmans-Paulssen, G. T. Fabius, et al. 1993. Diagnostic problems with imported cases of mycetoma in The Netherlands. Mycoses 36:81-87.
12. de Hoog, G. S., D. Adelmann, A. O. Ahmed, and A. van Belkum. 2004. Phylogeny and typification of Madurella mycetomatis, with a comparison of other agents of eumycetoma. Mycoses 47:121-130.
13. Desnos-Ollivier, M., S. Bretagne, F. Dromer, O. Lortholary, and E. Dannaoui. 2006. Molecular identification of black-grain mycetoma agents. J. Clin. Microbiol. 44:3517-3523.
14. Espinel-Ingroff, A., M. R. McGinnis, D. H. Pincus, P. R. Goldson, and T. M. Kerkering. 1989. Evaluation of the API 20C yeast identification system for the differentiation of some dematiaceous fungi. J. Clin. Microbiol. 27:2565-2569.
15. Fahal, A. H. 2004. Mycetoma: a thorn in the flesh. Trans. R. Soc. Trop. Med. Hyg. 98:3-11.
16. Gumaa, S. A., E. S. Mahgoub, and M. A. el Sid. 1986. Mycetoma of the head and neck. Am. J. Trop. Med. Hyg. 35:594-600.
17. Lopes, M. M., G. Freitas, and P. Boiron. 2000. Potential utility of random amplified polymorphic DNA (RAPD) and restriction endonuclease assay (REA) as typing systems for Madurella mycetomatis. Curr. Microbiol. 40:1-5.
18. Loulergue, P., A. Hot, E. Dannaoui, A. Dallot, S. Poirée, B. Dupont, and O. Lortholary. 2006. Successful treatment of black-grain mycetoma with voriconazole. Am. J. Trop. Med. Hyg. 75:1106-1107.
19. Lynch, J. B. 1964. Mycetoma in the Sudan. Ann. R. Coll. Surg. Engl. 35:319-340.
20. National Committee for Clinical Laboratory Standards. 2002. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi. Approved standard. Document M38-A. National Committee for Clinical Laboratory Standards, Wayne, PA.
21. Qin, Z. Y., S. X. Wu, R. L. Hopfer, G. X. Lv, C. J. Yao, and N. R. Guo. 2000. Glass beads-salting out procedure for extracting DNA from common pathogenic fungi. Chin. J. Dermatol. 33:330-332.
22. Rakeman, J. L., U. Bui, K. Lafe, Y. C. Chen, R. J. Honeycutt, and B. T. Cookson. 2005. Multilocus DNA sequence comparisons rapidly identify pathogenic molds. J. Clin. Microbiol. 43:3324-3333.
23. van de Sande, W. W., A. Luijendijk, A. O. Ahmed, I. A. Bakker-Woudenberg, and A. van Belkum. 2005. Testing of the in vitro susceptibilities of Madurella mycetomatis to six antifungal agents by using the Sensititre system in comparison with a viability-based 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino)carbonyl] -2H-tetrazolium hydroxide (XTT) assay and a modified NCCLS method. Antimicrob. Agents Chemother. 49:1364-1368.
24. van de Sande, W. W., R. Gorkink, G. Simons, A. Ott, A. O. Ahmed, H. Verbrugh, and A. van Belkum. 2005. Genotyping of Madurella mycetomatis by selective amplification of restriction fragments (amplified fragment length polymorphism) and subtype correlation with geographical origin and lesion size. J. Clin. Microbiol. 43:4349-4356.
25. Vilela, R., O. M. Duarte, C. A. Rosa, J. G. Castro, S. Lyon, R. L. Motta, and A. C. Moura. 2004. A case of eumycetoma due to Madurella grisea in northern Brazil. Mycopathologia 158:415-418.
26. White, T. J., T. Bruns, S. Lee, and J. Taylor. 1990. Amplification and direct sequencing of fungal ribosomal RNA genes for phylogenetics, p. 315-322. In M. A. Innis, D. H. Gelfand, J. J. Sninsky, and T. J. White (ed.), PCR protocols: a guide to methods and applications. Academic Press, San Diego, CA.
27. Zlotnik, H., and H. R. Buckley. 1980. Experimental production of actinomycetoma in BALB/c mice. Infect. Immun. 29:1141-1145.